Fluorometholone 0.1% Oph Susp

DRUG2 trials

Conditions

Eye DiseasesEyelid DiseasesFuchs' Endothelial DystrophyIntraocular PressurePseudophakic Bullous KeratopathyTrachomatousTrachomatous Trichiasis (TT)Trichiasis

Phase 3

FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial

CompletedNCT04149210

Massachusetts Eye and Ear InfirmaryEye Diseases, Eyelid Diseases, Trachomatous +2

Start: 2021-08-19End: 2024-11-30Updated: 2026-03-24

Phase 4

The OPTIMISE Study

RecruitingNCT05716945

Maastricht University Medical CenterFuchs' Endothelial Dystrophy, Intraocular Pressure, Pseudophakic Bullous Keratopathy

Start: 2024-07-29End: 2029-03-31Target: 342Updated: 2025-10-06

Related Papers

Evaluation of fluorometholone as adjunctive medical therapy for trachomatous trichiasis surgery (FLAME): a parallel, double-blind, randomised controlled field trial in the Jimma Zone, Ethiopia.

2026-01-12

Outcomes of posterior lamellar tarsal rotation vs bilamellar tarsal rotation for trachomatous trichiasis

PLoS neglected tropical diseases2025-07-301 citations

The FLuorometholone as Adjunctive MEdical Therapy for Trachomatous Trichiasis Surgery (FLAME) Trial: Study Design

Ophthalmic Epidemiology2024-11-011 citations

Fluorometholone 0.1% Oph Susp

Sponsors

Conditions

Phase 3

Phase 4

Related Papers